SCHEMBL9729324

SCHEMBL9729324

CCCN1CC(C(=O)O)CC2CC(=O)CCC21

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 3/20 0.33
DRD2 P14416 2/20 0.33
DRD1 P21728 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HTR1A P08908 2/20 0.32
NR1I2 O75469 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
SLC6A2 P23975 1/20 0.32
HTR2A P28223 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32
OPRK1 P41145 1/20 0.32
HTR2B P41595 1/20 0.32
KCNH2 Q12809 1/20 0.32
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11129414 0.85 HTT (0.37) SMN1; SMN2POLBMAPT
SCHEMBL15894829 0.85 HTT (0.37) SMN1; SMN2POLBMAPT
SCHEMBL9728987 0.85 HTT (0.37) SMN1; SMN2POLBMAPT
SCHEMBL11068690 0.85 HTT (0.37) SMN1; SMN2POLBMAPT
SCHEMBL15894833 0.84 MEN1 (0.37) DRD3DRD2DRD1SMN1; SMN2HTR1A
SCHEMBL9728745 0.80 BRD4 (0.36) DRD3DRD2DRD1HTR1ANR1I2
SCHEMBL9729363 0.80 BRD4 (0.36) DRD3DRD2DRD1HTR1ANR1I2
SCHEMBL9728744 0.80 BRD4 (0.36) DRD3DRD2DRD1HTR1ANR1I2
SCHEMBL15894838 0.78 CYP3A4 (0.46) MAPT
SCHEMBL15802828 0.77 DRD2 (0.38) DRD3DRD2DRD1SMN1; SMN2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5134143-A Dopamine Agonists ELI LILLY AND COMPANY (US) 1992-07-28 US disclosed
US-4977160-A DOPAMINE AGONISTS; PARKINSON*S DISEASE ELI LILLY AND COMPANY (US) 1990-12-11 US disclosed
US-4826986-A DOPAMINE AGONISTS ELI LILLY AND COMPANY (US) 1989-05-02 US disclosed
EP-0250179-A2 BCD tricyclic ergoline part-structure analogues ELI LILLY AND COMPANY (US) 1987-12-23 EP disclosed